Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nkarta, Inc.

Clinical trials sponsored by Nkarta, Inc., explained in plain language.

NKARTA, Inc. NKTX NASDAQ

Clinical-stage biotech developing natural killer cell therapies for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1

Off-the-Shelf cell therapy takes on tough blood cancers

Disease control Ongoing

This early-stage trial is testing an experimental therapy called NKX019 for people with certain blood cancers (like lymphoma and leukemia) that have come back or not responded to standard treatments. NKX019 uses donor immune cells (natural killer cells) that are engineered to fin…

Phase: PHASE1 • Sponsor: Nkarta, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC